Tag: insulin
-
ViCentra secures an additional $13M to accelerate growth and advance next-gen insulin system
Dutch-based medical device company ViCentra, which commercialises the Kaleido insulin patch pump system, has raised an additional $13 million as part of its Series D financing, bringing the total round to $98 million. The funding includes new capital from ROM Utrecht Region and a consortium of Dutch investors, including Venturing Tech, alongside increased support from read more
Written by
